Haemophilia A
Clinical trials for Haemophilia A explained in plain language.
Never miss a new study
Get alerted when new Haemophilia A trials appear
Sign up with your email to follow new studies for Haemophilia A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a lab-made antibody stop bleeding in a rare blood disorder?
Disease control Not yet recruitingResearchers are testing denecimig, an experimental antibody given as an injection under the skin, in adults newly diagnosed with acquired haemophilia A. This rare condition causes the immune system to attack a clotting protein, leading to sudden and sometimes severe bleeding. The…
Matched conditions: HAEMOPHILIA A
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 21, 2026 13:00 UTC
-
Patient voices take center stage in haemophilia a treatment decisions
Knowledge-focused Not yet recruitingThis study asks adults with haemophilia A in Germany to complete an online survey about their preferences for preventive treatments. Participants choose between hypothetical treatment options that vary in effectiveness, safety, and how they are given. The goal is to understand wh…
Matched conditions: HAEMOPHILIA A
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC